tinhat
Pocket Calculator Operator
- Joined
- 1 May 2009
- Posts
- 1,756
- Reactions
- 768
Tinhat
I was browsing on ACR threads and found your posting.
What do you think of your decision made in Feb 2013 with current price. Felt lucky hey?
great job done.
What do you think of ACR today ? Re-entry level ?
I would be interested to hear more on the outlook for this company from anyone who is following. I will look at it again when it demonstrates it is in an up-swing.
Drug delivery company Acrux has entered a trading halt on a day that investors sent the stock plunging on the back of reports that the United States regulator will investigate whether testosterone replacement therapy increases the risk of stroke and heart attack.
Drug delivery company Acrux Limited’s (ASX: ACR) shares have tumbled 10.3% before being placed in a trading halt at 2.56 pm on Tuesday.
Around 4.4 million shares had changed hands before the trading halt occurred, however the reason for the sell-off remains unclear.
Market routs such as this can create great buying opportunities for investors. Sell-offs are often sudden with subsequent rallies equally as quick. Savvy investors need to be alert and ready to act when opportunities present themselves.
Cochran Firm, D.C. Investigating AndroGel, Axiron and Other Potential Testosterone Replacement Therapy Lawsuit Cases
I owned Acrux but recently sold my stake on the back of the recent bad news. I've described my experience in more detail here.
I thought $1.955 was OK.
:hide:
Acrux Limited soars on positive quarterly sales numbers. The positive news would propel it up to 1.775 in short term according to au stoxline.
... I am missing something ...
S&P DJ Indices Announces September Quarterly Rebalance:
The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries serious risks.
I hope you all, had a trailing_stop in place!
Trading halted now...
Can't believe it was allowed to trade for almost an hr on the back of negative FDA panel recommendations.
Yes bloody slack governance by the board and ASX.. but great for holders who had their ears to the ground and get out on the open.
(Or shorters making a good profit)
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?